Pengaruh Suplementasi Vitamin C dan Multivitamin Mineral ... · 2004. Minerals. Di dalam: Mahan LK, Escott-Stump S, editor. Krause’s Food ... Peranan gizi pada pencegahan dan penanggulangan

65

DAFTAR PUSTAKA

[ACC/SCN] Administrative Committee on Coordination/Sub-Committee on

Nutrition. 2000. Fourth Report on the World Nutrition Situation. Geneva:

ACC/SCN.

[AHA] American Heart Association. 2000. About blood pressure.

http://www.americanheart.org/highbloodpressure [7 Juli 2008].

Almatsier S. 2003. Prinsip Dasar Ilmu Gizi. Jakarta: PT Gramedia Pustaka

Utama.

Anderson JJB. 2004. Minerals. Di dalam: Mahan LK, Escott-Stump S, editor.

Krause’s Food, Nutrition, & Diet Therapy. Ed ke-11. USA: Elsevier.

Bender DA. 2002. Introduction to Nutrition and Metabolism. 3rd

ed. New York:

Taylor & Francis Inc.

Beyer PL. 2004. Digestion, absorption, transport, and excretion of nutrients. Di

dalam: Mahan LK, Escott-Stump S, editor. Krause’s Food, Nutrition, &

Diet Therapy. Ed ke-11. USA: Elsevier.

Bloem MW, Matzger H, Huq N. 1994. Vitamin A deficiency among women in

the reproductive years: an ignored problem. Proceedings of the 16th

IVACG Meeting. 24-28 Oktober 1994. Chiang Rai. Thailand.

Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C,

Shen FH, Gandhi VC, Tucker CT, Curtis FK, Coburn JW. 1980. Methods

for assessing nutritional status of patients with renal failure. Am J Clin

Nutr 33:1567-1585.

[BPOM] Badan Pengawas Obat dan Makanan. 2004. Keputusan Kepala Badan

Pengawas Obat dan Makanan RI Nomor HK.00.05.23.3644 Tahun 2004

tentang Ketentuan Pokok Pengawasan Suplemen Makanan. Jakarta:

BPOM.

Brody T. 1999. Nutritional Biochemistry. 2nd

ed. San Diego: Academic Press.

Budiman H. 1999. Peranan gizi pada pencegahan dan penanggulangan hipertensi.

Jurnal Kedokteran dan Farmasi 12:784-788.

Bunk MJ, Dnistrian A, Schwartz MK, Rivlin RS. 1987. Dietary zinc deficiency

impairs plasma transport of vitamin E. Am J Clin Nutr 45:865.

Bunout D, Barrera G, de la Maza P, Avendano M, Gattas V, Petermann M, Hirsch

S. 2001. The impact of nutritional supplementation and resistance training

on the health functioning of free-living Chilean elders: results of 18

months of follow-up. J Nutr 131:2441S-2446S.

http://www.americanheart.org/highbloodpressure

66

Chandler CJ, Wang TY, Halsted CH. 1986. Pteroylpolyglutamate hydrolase from

human jejunal brush border: purification and characterization. J Biol

Chem 261:928.

[Depkes RI] Departemen Kesehatan Republik Indonesia. 1990. Komposisi Zat

Gizi Pangan Indonesia. Jakarta: Depkes.

_________. 1996. Pedoman Praktis Menilai Status Gizi Orang Dewasa. Jakarta:

Depkes.

[Dirjen POM] Direktorat Jenderal Pengawasan Obat dan Makanan. 1996. Surat

Keputusan Direktur Jenderal Pengawasan Obat dan Makanan tentang

Suplemen Makanan Nomor HK.00.063.02360 Tahun 1996. Jakarta:

Dirjen POM.

Fairweather-Tait SJ. 1997. From absorption and excretion of minerals to the

importance of bioavailability and adaptation. J Nutr 130(S):95(S)-100(S).

[FAO/WHO] Food and Agriculture Organization/World Health Organization.

1992. International Conference on Nutrition. World Declaration and Plan

of Action for Nutrition. Roma: FAO.

_________. 2001. Human Vitamin and Mineral Requirement. Report of a joint

FAO/WHO expert consultation. Bangkok, Thailand. Roma: Food and

Nutrition Division.

FAO/WHO/UNU. 1985. Energy and Protein Requirements. Geneva.

Foote JA, Murphy SP, Wilkens LR, Hankin JH, Henderson BE, Kolonel LN.

2003. Factors associated with dietary supplement use among healthy

adults of five ethnicities. Am J Epidemiol 157(10):888-897.

Fosmire G. 1990. Zinc toxicity. Am J Clin Nutr 51:225-227.

Gallagher ML. 2004. Vitamins. Di dalam: Mahan LK, Escott-Stump S, editor.

Krause’s Food, Nutrition, & Diet Therapy. Ed ke-11. USA: Elsevier.

Gibson RS. 2005. Principles of Nutritional Assessment. Ed ke-2. New York:

Oxford University Press.

Goodman S. 1991. Vitamin C The Master Nutrient. Connecticut: Keats Publishing

Inc.

Guyton AC. 1995. Fisiologi Manusia dan Mekanisme Penyakit. Andrianto P,

penerjemah. Jakarta: EGC. Terjemahan dari: Human Physiology and

Mechanisms of Disease.

67

Hardinsyah, Briawan D. 1994. Penilaian dan Perencanaan Konsumsi Pangan.

Bogor: Jurusan Gizi Masyarakat dan Sumberdaya Keluarga Fakultas

Pertanian IPB.

Hathcock JN. 1997. Vitamins and minerals: efficacy and safety. Am J Clin Nutr

66:427-437.

________, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, Jialal I, Johnston

CS, Kelly FJ, Kraemer K, Packer L, Parthasarathy S, Sies H, Traber MG.

2005. Vitamins E and C are safe across a broad range of intakes. Am J

Clin Nutr 81:736-745.

[IOM] Institute of Medicine. 1997. Dietary Reference Intakes For Calcium,

Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington DC:

National Academy Press.

_________. 1998. Dietary Reference Intakes For Thiamin, Riboflavin, Niacin,

Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline.

Washington DC: National Academy Press.

_________. 2000. Dietary Reference Intakes For Vitamin C, Vitamin E, Selenium,

and Carotenoids. Washington DC: National Academy Press.

_________. 2000. Dietary Reference Intakes. Applications in Dietary Assessment.

Washington DC: National Academy Press.

_________. 2001. Dietary Reference Intakes For Vitamin A, Vitamin K, Arsenic,

Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum,

Nickel, Silicon, Vanadium, and Zinc. Washington DC: National Academy

Press.

Jelliffe DB, Jelliffe EFP. 1989. Community Nutritional Assessment. New York:

Oxford University Press.

Jenkins DJA, Kendall CWC, Vidgen E, Augustin LSA, van Erk M, Geelen A,

Parker T, Faulkner D, Vuksan V, Josse RG, Leiter LA, Connelly PW.

2001. High-protein diets in hyperlipidemia: effect of wheat gluten on

serum lipids, uric acid, and renal function. Am J Clin Nutr 74:57-63.

Kotchen TA, Kotchen JM. 2006. Nutrition, Diet, and Hypertension. Di dalam:

Shils ME, Shike M, Ross C, Caballero B, Cousins RJ, editor. Modern

Nutrition in Health and Disease. Ed ke-10. Baltimore: Lippincot Williams

& Wilkins.

Krebs NF. 2001. Bioavailability of dietary supplements and impact of physiologic

state: infants, children and adolescents. J Nutr 131:1351(S)-1354(S).

68

Kumar P, Clark M. 2005. Clinical Medicine. Ed ke-6. Edinburgh: Elsevier

Saunders.

Linder MC. 2006. Biokimia Nutrisi dan Metabolisme dengan Pemakaian Secara

Klinis. Parakkasi A, penerjemah. Jakarta: UI-Press. Terjemahan dari:

Nutritional Biochemistry and Metabolism with Clinical Application.

Lonnerdal B. 1988. Vitamin mineral interaction. Di dalam: Bodwell CE, Erdman

JW, editor. Nutrient Interactions. New York: Marcel Dekker Inc.

Lyle BJ, Mares-Perlman JA, Klein BEK, Klein R, Greger JL. 1998. Supplement

users differ from nonusers in demographic, lifestyle, dietary and health

characteristics. J Nutr 128:2355-2362.

Machlin LJ, Langseth L. 1988. Vitamin-vitamin interaction. Di dalam: Bodwell

CE and Erdman JW, editor. Nutrient Interactions. New York: Marcel

Dekker Inc.

Mattjik AA, Sumertajaya M. 2002. Perancangan Percobaan. Ed ke-2. Bogor: IPB

Press.

McNaughton SA, Mishra GD, Paul AA, Prynne CJ, Wadsworth MEJ. 2005.

Supplement use is associated with health status and health-related

behaviors in the 1946 British birth cohort. J Nutr 135:1782-1789.

Meydani SN, Meydani M, Blumberg JB, Leka LS, Pedrosa M, Diamond R,

Schaefer EJ. 1998. Assessment of the safety of supplementation with

different amount of vitamin E in healthy older adults. Am J Clin Nutr

63:311-318.

Muhilal, Hardinsyah. 2004. Penentuan kebutuhan gizi dan kesepakatan

harmonisasi di Asia Tenggara. Prosiding Widyakarya Nasional Pangan

dan Gizi VIII. Jakarta: Lembaga Ilmu Pengetahuan Indonesia.

Murphy SP, White KK, Park Song-Yi, Sharma S. 2007. Multivitamin-

multimineral supplements’ effect on total nutrient intake. Am J Clin Nutr

85:280S-284S.

Mulholland CA, Benford DJ. 2007. What is known about the safety of

multivitamin-multimineral supplements for the generally healthy

population? Theoretical basis for harm. Am J Clin Nutr 85:318S-322S.

Neuhouser ML. 2003. Dietary supplement use by American women: challenges in

assessing patterns of use, motives and costs. J Nutr 133:1992S-1996S.

Nieman DC. 2001. Does exercise alter immune function and respiratory

infections? President’s Council on Physical Fitness and Sports. Research

Digest 3(13).

69

NIH State of the Science Panel. 2007. National Institute of Health State-of-the

Science Conference Statement: Multivitamin/mineral supplements and

chronic disease prevention. Am J Clin Nutr 85:257S-264S.

Official Journal of the European Communities. 2002. Directive 2002/46/EC of the

European Parliament and of the Council of 10 June 2002 on the

approximation of the laws of the Member States relating to food

supplements. http://europa.eu.int/eur-lex/pri/en/oj/dat/2002/I_183/I_183

20020712en00510057.pdf [20 Mei 2008].

Park Song-Yi, Murphy SP, Wilkens LR, Yamamoto JF, Kolonel LN. 2006.

Allowing for variations in multivitamin supplement composition improves

nutrient intake estimates for epidemiologic studies. J Nutr 136:1359-1364.

Pearce E. 2006. Anatomi dan Fisiologi untuk Paramedis. Handoyo SY,

penerjemah. Jakarta: PT Gramedia Pustaka Utama. Terjemahan dari:

Anatomy and Physiology for Nurses.

Purwati S, Salimar, Rahayu S. 2002. Perencanaan Menu Untuk Penderita

Tekanan Darah Tinggi. Jakarta: Penebar Swadaya.

Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. 2004.

Dietary supplement use by US adults: data from the National Health and

Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160:339-349.

Ransley JK. 2001. The Rise and Rise of Food and Nutritional Supplements-an

Overview of the Market. Di dalam: Ransley JK, Donnelly JK, Read NW,

editor. Food and Nutritional Supplements Their Role in Health and

Disease. Jerman: Springer.

Read NW. 2001. Placebo and Panacea: The Healing Effect of Nutritional

Supplements. Di dalam: Ransley JK, Donnelly JK, Read NW, editor.

Food and Nutritional Supplements Their Role in Health and Disease.

Jerman: Springer.

Riyadi H. 2001. Metode Penilaian Status Gizi Secara Antropometri. Bogor:

Jurusan Gizi Masyarakat dan Sumberdaya Keluarga Fakultas Pertanian

IPB.

Romeo J, Wärnberg J, Gomez-Martínez S, Díaz LE, Marcos A. 2008.

Neuroimmunomodulation by nutrition in stress situations [abstrak].

Neuroimmunomodulation 15:165.

Romieu T. 2005. Nutrition and lung health. Int J Tuberc Lung Dis 9:362-374.

Sastroasmoro S, Ismael S. 2002. Dasar-dasar Metodologi Penelitian Klinis.

Jakarta: Sagung Seto.

http://europa.eu.int/eur-lex/pri/en/oj/dat/2002/I_183/I_183%2020020712en00510057.pdf

http://europa.eu.int/eur-lex/pri/en/oj/dat/2002/I_183/I_183%2020020712en00510057.pdf

70

Singh A, Moses FM, Deuster PA. 1992. Vitamin and mineral status in physically

active men: effects of a high-potency supplement. Am J Clin Nutr 55:1-7.

Slesinski MJ, Subar AF, Kahle LL. 1996. Dietary intake of fat, fiber, and other

nutrients is related to the use of vitamin and mineral supplements in the

United States: The 1992 National Health Interview Survey. J Nutr

126:3001-3008.

Soekirman. 2000. Ilmu Gizi dan Aplikasinya Untuk Keluarga dan Masyarakat.

Jakarta: Direktorat Jenderal Pendidikan Tinggi Departemen Pendidikan

Nasional.

Solomons NW. 1988. Physiological interactions of minerals. Di dalam: Bodwell

CE, Erdman JW, editor. Nutrient Interactions. New York: Marcel Dekker

Inc.

__________. 2001. What impact does stage of physiological development and/or

physiological state have on bioavailability of dietary supplements?

Summary of Workhsop Discussion. J Nutr 131:1392S-1395S.

Steel RGD, Torrie JH. 1995. Prinsip dan Prosedur Statistika. Sumantri B,

penerjemah. Jakarta: PT Gramedia Pustaka Utama. Terjemahan dari:

Principles and Procedures of Statistics.

Suharno D, Muhilal. 1996. Vitamin A and nutritional anaemia. Food and

Nutrition Bulletin 17(1):7-10.

Sunde RA. 2001. Selenium. Di dalam: Bowman BA, Russell RM, editor. Present

Knowledge in Nutrition. Ed ke-8. Washington DC: ILSI Press.

Supariasa IDN, Bakri B, Fajar I. 2002. Penilaian Status Gizi. Jakarta: EGC.

Suryaatmadja M, Sosro R. 1990. Tes faal ginjal dan manfaatnya di klinik. Cermin

Dunia Kedokteran 30:39-44.

Tortora GJ, Anagnostakos NP. 2002. Principles of Anatomy and Physiology. 10th

ed. New York: John Wiley & Sons. Ltd.

US Food and Drug Administration, Center for Food Safety and Applied Nutrition.

2001. Overview of dietary supplements. http://www.cfsan.fda.gov/~dms

/ds-oview.html#what [20 Mei 2008].

Vander A, Sherman J, Luciano D. 2001. Human Physiology: The Mechanisms of

Body Function. Ed ke-8. New York: Mc-Graw Hill.

[WHO] World Health Organization. 1998. Safe vitamin A dosage during

pregnancy and lactation. Recommendations and report from a

consultation. Micronutrient series. Geneva: WHO.

http://www.cfsan.fda.gov/~dms%20/ds-oview.html#what



71

Widyakarya Nasional Pangan dan Gizi VIII. 2004. Ketahanan Pangan dan Gizi di

Era Otonomi Daerah dan Globalisasi. Jakarta: Lembaga Ilmu

Pengetahuan Indonesia.

Wildman REC, Medeiros DM. 2000. Advanced Human Nutrition. Florida: CRC

Press.

Woods HF. 2001. The Addition of Micronutrients to Food. Di dalam: Ransley JK,

Donnelly JK, Read NW, editor. Food and Nutritional Supplements Their

Role in Health and Disease. Jerman: Springer.

Yetley EA. 2007. Multivitamin and mineral dietary supplements: definitions,

characterization, bioavailability, and drug interactions. Am J Clin Nutr

85:269S-276S.

Yip R. 2001. Iron. Di dalam: Bowman BA, Russell RM, editor. Present

Knowledge in Nutrition. Ed ke-8. Washington DC: ILSI Press.

73

Lampiran 1 Persetujuan etik (ethical clearance)

74

Lampiran 2 Formulir persetujuan untuk mengikuti penelitian (informed consent)

SURAT PERSETUJUAN UNTUK MENGIKUTI PENELITIAN

Yang bertanda tangan di bawah ini :

Nama :

Umur :

Alamat :

telah mendapat penjelasan dan mengerti tentang penelitian “Pengaruh

Suplementasi Multivitamin Mineral Terhadap Imunitas Humoral, Seluler, dan

Status Zat Gizi Antioksidan“ dan setuju untuk ikut dalam penelitian ini, dengan

catatan bahwa bila suatu waktu merasa dirugikan dalam bentuk apapun kami

berhak untuk membatalkan persetujuan ini.

Bogor, ............................ 2008

Mengetahui,

Manager Perusahaan Yang menyetujui,

____________________ __________________

75

Lampiran 3 Kuisioner status gizi dan kesehatan wanita pekerja

PENGARUH SUPLEMENTASI VITAMIN C DAN

MULTIVITAMIN MINERAL TERHADAP IMUNITAS HUMORAL,

SELULER, DAN STATUS ZAT GIZI ANTIOKSIDAN

Tanggal Wawancara : …................... Kode : A/B/C

Enumerator : ....................... No. :

I. IDENTITAS RESPONDEN

1. Nama : ……………………………………………..

2. Tanggal lahir/ Umur : ................................/ tahun

3. Status perkawinan : 1. Menikah 2. Janda

4. Pendidikan terakhir : 1. Tidak sekolah 2. Tidak tamat SD

3. Tamat SD 4.. Tamat SLTP

5. Tamat SLTA 6. Tamat D1/D3

7. Tamat S1

5. Jenis pekerjaan : 1. Pekerja tetap 2.. Tidak tetap

6. Devisi pekerjaan : …………………………..

7. Merokok : 1. ya 2. tidak

8. Minum alkohol : 1. ya 2. tidak

9. Sedang berdiit : 1. ya 2. tidak

10. Berapa kali ibu pernah melahirkan :

1. ................. kali

2. Jumlah anak hidup : ..................

3. Jumlah anak meninggal: ..................

4. Jumlah anak keguguran : .................

11. Jumlah Anggota Keluarga : …. orang

12. Ikut serta KB : 1. ya 2. tidak

Bila ya, lanjut no 13, bila tidak lanjut ke no.14

13. Jenis KB : 1. Pil 2. suntik (......bln/x, tgl.….)

3. IUD 4. Spiral

5. Steril 6. Kondom

7. Implant/susuk

76

14. Apakah ibu melakukan olah raga?

1. ya 2. tidak

Bila ya, lanjut ke no.15, bila tidak stop

15. Jenis olah raga yang biasa dilakukan :

a. Jogging

b. Senam

c. Badminton

d. Lainnya…………………

16. Lama tiap kali olah raga………..menit

17. Berapa kali melakukan olah raga dalam 1 minggu? (……..kali/minggu)

II. ANTROPOMETRI RESPONDEN

1. Berat badan : ..................kg

2. Tinggi badan : ..................cm

3. LILA : ..................cm

III. SOSIAL EKONOMI

1. Penghasilan istri per bulan Rp............................

2. Penghasilan suami per bulan Rp.............................

3. Penghasilan tambahan istri per bulan Rp.............................

4. Penghasilan tambahan suami per bulan Rp.............................

77

IV. PEMERIKSAAN KESEHATAN

Data Dasar Morbiditas

1. Apakah ibu sedang mendapat menstruasi ?

1. Ya 2. Tidak

2. Apakah dalam 2 bulan terakhir Ibu menderita sakit :

Jenis penyakit Ya/tidak Jika ya, berapa

hari

Dibawa kemana*

Panas/demam

Batuk

Pilek

Diare

Lainnya

* : 1 = Puskesmas, 2= Rumah sakit, 3= Klinik, 4= Diobati sendiri

3. Apakah dalam 1 bulan terakhir hingga saat ini Ibu menderita sakit :


hari

Dibawa kemana*

Panas/demam

Batuk

Pilek

Diare

Lainnya


78

V. PEMERIKSAAN KLINIS

Pemeriksaan Fisik

Vital sign: TD:......... Suhu: N/…………. Nadi: N/…........ Pernafasan: N/............

1. Keadaan umum: 1. tampak sehat 2. tampak sakit

2. Wajah 1. normal 2. .............

3. Mata: a. Conjungtiva mata 1. normal 2. pucat

b. Sklera mata 1. normal 2. ikterik

c. Lainnya. ............... ...............

4. Telinga 1.normal 2. tuli

5. Hidung 1. normal 2. ..............

6. Tenggorokan 1. normal 2. ……......

7. Mulut 1. normal 2. .……….

8. Gigi 1. normal 2. ……….

9. Leher 1. normal 2...............

10. a. Jantung 1. normal 2...............

b. Thorax/paru-paru 1. normal 2. ..............

11. Abdomen: a. Hati 1. normal 2. ..............

b. Limpa 1. normal 2. ..............

12. Genital 1. normal 2. ..............

13. Ekstremitas atas 1. normal 2. ..............

14. Ekstremitas bawah 1. normal 2. ..............

15. Kulit 1. normal 2. ..............

Diagnosis kerja/kesimpulan: 1. Sehat

2. Tidak sehat, sebutkan......................

Anamnese penyakit yang pernah diderita sebelumnya/penyakit dahulu

----------------------------------------------------------------------------------------

----------------------------------------------------------------------------------------

79

VI. KONSUMSI PANGAN

Recall 2 X 24 jam Hari Ke :

Nama Responden : ............................. Petugas: .....................

Tanggal : .............................

Waktu Nama

Makanan/minuman

Nama

Bahan

Makanan

Jumlah

URT Gram

1. Pagi

2. Siang

3. Malam

80

Food Frequencies Questionare

Nama Responden : ..................... Petugas : .................

Tanggal : ......................

Bahan

makanan

Frekuensi konsumsi makanan

1x

/hr

2-3x

/hr

3-5x

/mg

1-2x

/mg

2-3x

/bln

1x

/bl

Tidak

pernah

Nasi

Mie

Roti

Jagung

Biskuit

Kacang Ijo

Kacang Merah

Melinjo

Ubi Jalar

Tempe

Tahu

Telur

Oncom

Ayam

Daging Sapi

Hati sapi

Hati ayam

Ikan segar

Bayam

Kangkung

Daun singkong

Kac.Panjang

Selada air

Sawi

Daun katuk

Jambu Biji

Pepaya

Jeruk

Salak

Susu bubuk

Keju

Lainnya

81

VII. FORMULIR MONITORING INTERVENSI

Kode : A/B/C Nama Responden :

No. : Petugas :

Minggu ke Tgl Minum

Suplemen

Minggu ke Tgl Minum

Suplemen

Hari Ya Tidak Hari Ya Tidak

I VI

II VII

III VIII

IV IX

V X

82

VIII. DATA MONITORING MORBIDITAS

Apakah dalam 1 minggu terakhir hingga saat ini Ibu menderita sakit :


hari

Dibawa

kemana*

Panas/demam

Batuk

Pilek

Diare

Lainnya


83

Lampiran 4 Prosedur penentuan urea serum darah

Analisis urea serum ditentukan dengan kit Fluitest®

Urea col. Biocon Jerman

berdasarkan metode Berthelot.

Prinsip uji

Pemisahan urea secara enzimatik berdasarkan reaksi berikut:

Urease

Urea + H2O + 2 H+

2 NH4 + CO2

Ion natrium yang terbentuk bereaksi dengan salisilat dan hipoklorida hingga

berwarna hijau (2.2 dikarboksilindofenol).

Reagen

Reagen 1 (R1) mengandung buffer fosfat dengan pH 6.7, EDTA, natrium salisilat,

dan natrium nitroprusida. R2 mengandung urease, R3 mengandung natrium

hipoklorida dan natrium hidroksida, sedangkan R4 (standar) mengandung urea.

Prosedur

Panjang gelombang : 580-600 nm

Suhu : +37oC

Kuvet kaca : 1 cm

Pengukuran terhadap reagen blanko (RB) dilakukan satu kali untuk satu seri

pemeriksaan.

Dipipet ke dalam kuvet Reagen blanko Standar Sampel

Working solution 1000 μl 1000 μl 1000 μl

Standar (R4) -- 10 μl --

Sampel -- -- 10 μl

Reagen-reagen ini dicampur, kemudian diinkubasi pada suhu 37oC selama 5 menit

lalu ditambahkan R3 200 μl untuk reagen blanko, 200 μl untuk standar, dan 200 μl

untuk sampel. Dicampurkan, lalu diinkubasi pada suhu 37oC selama 5 menit

kemudian dibaca absorbansi sampel dan standar terhadap reagen blanko (∆A).

Perhitungan

Konsentrasi urea (mg/dl) = (∆A sampel/∆A standar) x konsentrasi standar

84

Lampiran 5 Prosedur penentuan kreatinin serum darah

Analisis kreatinin serum ditentukan dengan kit Fluitest® Crea Kinetic

Biocon Jerman berdasarkan metode Jaffe.

Prinsip uji

Pengujian berdasarkan uji kinetik kolorimetrik dengan reaksi:

larutan alkali

kreatinin + asam pikrik kompleks kreatinin-asam

pikrik

Pada larutan alkali, kreatinin membentuk kompleks kuning-oranye dengan pikrat.

Intensitas warna secara langsung proporsional dengan konsentrasi kreatinin dan

dapat diukur secara fotometrik.

Reagen

Reagen 1 (R1) mengandung asam pikrik, R2 mengandung natrium hidroksida,

sedangkan R4 mengandung kreatinin.

Prosedur

Panjang gelombang : 492 nm (480-520 nm)

Suhu : +37oC

Kuvet kaca : 1 cm

Dipipet ke dalam kuvet Semi mikro

Working solution 1000 μl 1000 μl

Standar (R4) 100 μl --

Sampel -- 100 μl

Reagen-reagen ini dicampur, kemudian segera dituangkan ke dalam kuvet. Setelah

20 detik baca A1 sampel dan standar, kemudian 80 detik setelah pembacaan

pertama segera baca A2 sampel dan standar.

85

Lampiran 6 Antropometri wanita pekerja sebelum dan setelah suplementasi

a. Antropometri perlakuan plasebo

Wanita pekerja

Sebelum Setelah

BB

(kg)

TB

(cm)

IMT

(kg/m2)

BB

(kg)

TB

(cm)

IMT

(kg/m2)

1 39.5 149.2 17.7 40.5 149.1 18.2

2 66.3 154.7 27.7 65.6 155.7 27.1

3 68.4 159.4 26.9 68.1 160.8 26.3

4 48.4 146.1 22.7 48.0 146.8 22.3

5 66.2 153.8 28.0 67.2 154.8 28.0

6 57.8 149.5 25.9 60.0 148.8 27.1

7 50.9 153.0 21.7 50.3 153.6 21.3

8 43.2 145.7 20.4 43.6 146.5 20.3

9 52.4 151.0 23.0 50.5 151.0 22.1

10 57.6 152.1 24.9 57.8 152.0 25.0

11 49.0 160.8 19.0 50.8 160.8 19.6

12 49.9 156.0 20.5 50.4 156.6 20.6

13 42.8 151.1 18.7 43.5 151.3 19.0

14 43.6 144.9 20.8 43.8 145.7 20.6

15 44.1 148.5 20.0 43.5 148.9 19.6

16 46.1 144.0 22.2 45.2 143.9 21.8

17 68.0 150.0 30.2 66.7 149.0 30.0

18 50.9 159.1 20.1 51.2 159.0 20.3

19 47.0 143.0 23.0 47.2 143.2 23.0

20 59.2 151.5 25.8 60.0 152.0 26.0

21 56.1 153.8 23.7 54.0 154.0 22.8

22 42.3 148.9 19.1 43.1 149.2 19.4

23 42.2 145.5 19.9 41.3 145.3 19.6

24 64.4 152.3 27.8 65.5 150.5 28.9

25 64.7 150.9 28.4 64.1 149.5 28.7

26 64.0 151.0 28.1 64.3 151.5 28.0

27 55.9 154.5 23.4 54.8 152.0 23.7

28 65.1 156.9 26.4 65.7 155.0 27.3

29 55.8 149.0 25.1 53.9 148.0 24.6

30 75.1 156.4 30.7 75.3 157.0 30.5

31 53.9 150.6 23.8 54.5 149.5 24.4

86

b. Antropometri perlakuan vitamin C

Wanita

pekerja

Sebelum Setelah

BB

(kg)

TB

(cm)

IMT

(kg/m2)

BB

(kg)

TB

(cm)

IMT

(kg/m2)

1 51.3 146.7 23.8 51.8 147.7 23.7

2 39.6 145.7 18.7 39.2 146.9 18.2

3 39.3 151.6 17.1 39.6 151.6 17.2

4 53.7 153.7 22.7 52.4 154.6 21.9

5 48.3 150.8 21.2 50.1 153.6 21.2

6 63.3 157.6 25.5 62.0 157.4 25.0

7 35.1 145.0 16.7 34.6 145.3 16.4

8 44.1 155.1 18.3 44.3 155.2 18.4

9 54.0 151.8 23.4 53.7 152.7 23.0

10 53.1 150.8 23.4 51.4 150.8 22.6

11 66.4 149.5 29.7 66.6 149.8 29.7

12 45.9 142.8 22.5 45.8 141.4 22.9

13 52.8 151.0 23.2 51.9 149.0 23.4

14 61.1 158.8 24.2 60.5 157.9 24.3

15 50.1 151.8 21.7 48.9 149.5 21.9

16 44.5 155.4 18.4 44.7 153.3 19.0

17 45.1 150.6 19.9 47.6 150.4 21.0

18 47.2 147.5 21.7 46.8 147.4 21.5

19 45.5 153.5 19.3 44.1 152.0 19.1

20 49.6 150.0 22.0 49.9 149.9 22.2

21 65.2 161.5 25.0 54.0 157.0 21.9

22 58.7 150.5 25.9 59.4 151.3 25.9

23 45.5 147.5 20.9 45.8 147.3 21.1

24 64.9 151.0 28.5 64.5 152.6 27.7

25 57.0 150.2 25.3 57.8 148.9 26.1

26 55.6 157.4 22.4 55.9 157.0 22.7

27 59.8 140.3 30.4 60.8 141.0 30.6

28 44.1 146.5 20.5 42.7 147.0 19.8

29 44.8 147.6 20.6 44.6 147.6 20.5

30 56.7 147.2 26.2 55.4 146.0 26.0

31 42.4 146.7 19.7 42.1 147.2 19.4

87

c. Antropometri perlakuan multivitamin mineral

Wanita

pekerja

Sebelum Setelah

BB

(kg)

TB

(cm)

IMT

(kg/m2)

BB

(kg)

TB

(cm)

IMT

(kg/m2)

1 54.7 152.5 23.5 54.0 152.5 23.2

2 50.8 140.6 25.7 48.5 141.0 24.4

3 44.2 143.3 21.5 44.9 143.5 21.8

4 42.0 145.5 19.8 42.2 146.1 19.8

5 48.0 145.6 22.6 48.3 147.0 22.4

6 43.5 145.0 20.7 43.1 146.1 20.2

7 58.5 147.4 26.9 58.9 147.8 27.0

8 41.4 142.7 20.3 42.4 142.5 20.9

9 52.8 154.8 22.0 53.0 155.2 22.0

10 58.9 151.4 25.7 59.0 151.8 25.6

11 66.2 153.0 28.3 64.3 151.2 28.1

12 48.0 144.7 22.9 48.4 145.5 22.9

13 54.8 147.2 25.3 54.4 147.0 25.2

14 55.4 149.1 24.9 55.6 149.0 25.0

15 48.7 150.5 21.5 49.7 150.7 21.9

16 58.7 155.7 24.2 57.6 156.0 23.7

17 47.7 153.0 20.4 46.3 153.7 19.6

18 45.9 148.5 20.8 44.9 150.0 20.0

19 54.5 152.5 23.4 52.7 152.6 22.6

20 58.4 153.6 24.8 59.9 151.7 26.0

21 55.2 153.2 23.5 53.9 152.5 23.2

22 36.9 144.4 17.7 37.0 145.0 17.6

23 47.8 143.2 23.3 47.1 143.1 23.0

24 62.7 161.8 24.0 62.6 160.7 24.2

25 56.3 155.0 23.4 56.6 153.0 24.2

26 51.7 143.0 25.3 52.7 142.5 26.0

27 52.5 155.4 21.7 52.1 152.7 22.3

28 50.0 150.2 22.2 48.7 148.5 22.1

29 54.9 150.7 24.2 53.5 148.2 24.4

30 57.0 152.0 24.7 56.5 149.0 25.4

31 63.8 161.2 24.6 62.8 159.4 24.7

88

Lampiran 7 Monitoring morbiditas wanita pekerja selama suplementasi

a. Rata-rata lama sakit

Perlakuan Rata-rata lama sakit (hari)

Plasebo 4,3±4,9

Vit. C 2,1±2,8

MVM 2,5±3,6

b. Tempat berobat ketika sakit

Tempat berobat Perlakuan

Plasebo Vit. C MVM

Diobati sendiri 16 (69,6%) 17 (89,5%) 10 (71,4%)

Klinik 5 (21,7%) 2 (10,5%) 3 (21,4%)

Rumah sakit 1 (4,3%) 0 (0,0%) 1 (7,2%)

Puskesmas 1 (4,3%) 0 (0,0%) 0 (0,0%)

Total 23 (100,0%) 19 (100,0%) 14 (100,0%)

89

Lampiran 8 Tekanan darah sistolik dan diastolik wanita pekerja sebelum dan

setelah suplementasi

a. Tekanan darah perlakuan plasebo

Wanita pekerja Sebelum Setelah

Sistolik Diastolik Sistolik Diastolik

1 90 60 100 70

2 90 60 90 60

3 90 60 100 70

4 145 90 140 90

5 120 80 110 70

6 110 70 110 70

7 90 60 90 60

8 90 60 100 70

9 90 60 110 70

10 100 70 100 70

11 90 60 90 60

12 90 60 90 60

13 90 60 90 60

14 120 80 130 80

15 100 70 110 70

16 110 70 100 70

17 110 70 100 70

18 100 70 90 60

19 100 70 100 70

20 110 70 100 70

21 110 70 110 70

22 90 60 90 60

23 90 60 110 70

24 100 70 90 60

25 110 70 90 60

26 90 60 90 60

27 90 60 90 60

28 110 70 90 60

29 90 60 90 60

30 90 60 90 60

31 90 60 90 60

90

b. Tekanan darah perlakuan vitamin C



1 90 60 110 70

2 90 60 90 60

3 100 70 100 70

4 100 60 90 60

5 90 60 90 60

6 110 70 90 60

7 110 70 100 70

8 100 70 100 70

9 110 70 90 60

10 90 60 100 70

11 90 60 90 60

12 110 70 90 60

13 100 70 100 70

14 90 60 90 60

15 110 70 110 70

16 90 60 90 60

17 100 70 100 70

18 110 70 100 70

19 90 60 90 60

20 90 60 90 60

21 100 70 100 70

22 100 70 90 60

23 100 70 110 70

24 110 70 90 60

25 100 70 90 60

26 90 60 100 70

27 110 70 100 70

28 90 60 90 60

29 90 60 90 60

30 90 60 100 70

31 100 70 90 60

91

c. Tekanan darah perlakuan multivitamin mineral



1 90 60 90 60

2 100 70 90 60

3 100 70 90 60

4 160 100 140 100

5 110 70 110 70

6 90 60 90 60

7 100 70 110 70

8 90 60 90 60

9 100 70 100 70

10 100 70 90 60

11 110 70 100 70

12 90 60 90 60

13 90 60 90 60

14 100 70 100 70

15 90 60 90 60

16 90 60 90 60

17 90 60 90 60

18 90 60 90 60

19 90 60 90 60

20 90 60 100 70

21 90 60 90 60

22 90 60 90 60

23 110 70 100 70

24 90 60 90 60

25 120 80 130 80

26 100 70 90 60

27 90 60 90 60

28 90 60 110 70

29 100 70 100 70

30 100 70 90 60

31 110 70 110 70

92

Lampiran 9 Kadar urea dan kreatinin wanita pekerja sebelum dan setelah

suplementasi

a. Kadar urea dan kreatinin perlakuan plasebo

Wanita pekerja Urea Kreatinin

Sebelum Setelah Sebelum Setelah

1 21.9 25.9 0.9 0.7

2 18.6 23.8 0.6 0.6

3 22.5 25.0 1.0 0.7

4 17.9 24.1 0.9 0.7

5 16.9 19.3 0.8 0.6

6 13.3 22.4 0.9 1.0

7 18.7 24.3 0.9 0.7

8 21.6 16.7 1.0 0.7

9 10.2 23.3 0.8 1.0

10 17.1 15.4 0.9 0.9

11 11.4 14.0 0.9 0.8

12 15.5 10.7 1.0 0.9

13 21.6 15.9 0.7 1.0

14 27.9 30.6 0.5 0.4

15 26.6 12.6 0.9 0.8

16 18.9 25.0 0.9 0.9

17 16.0 24.3 0.8 0.8

18 18.5 16.8 0.8 0.8

19 24.0 22.5 0.8 0.8

20 23.0 14.9 0.8 0.8

21 25.0 25.6 0.8 0.7

22 28.8 18.3 0.9 0.7

23 13.7 18.7 1.0 0.9

24 16.5 24.1 0.6 0.8

25 14.8 22.7 0.9 1.0

26 20.3 20.0 0.7 1.0

27 19.9 17.9 1.0 0.8

28 19.5 21.7 0.9 0.8

29 29.7 32.5 1.0 0.8

30 19.3 22.1 0.8 1.0

31 14.8 24.6 0.8 0.8

93

b. Kadar urea dan kreatinin perlakuan vitamin C


Sebelum Setelah Sebelum Setelah

1 16.2 18.7 1.0 1.0

2 25.5 27.8 0.8 0.8

3 23.3 22.7 0.9 0.8

4 18.7 18.8 0.8 0.8

5 22.3 15.7 0.8 0.6

6 17.2 20.7 0.9 0.9

7 13.7 18.6 0.9 0.9

8 16.0 20.0 0.8 0.9

9 14.3 18.0 0.8 0.9

10 20.2 12.8 0.7 0.6

11 20.1 18.1 0.8 0.8

12 21.6 26.2 0.7 0.8

13 17.4 18.6 0.7 0.9

14 17.3 18.3 0.8 0.9

15 16.1 22.7 0.9 0.9

16 23.2 25.0 0.9 0.9

17 26.8 30.1 0.7 1.0

18 28.3 31.4 0.7 0.9

19 21.8 25.0 0.8 0.8

20 8.0 21.8 0.7 1.0

21 15.0 16.7 0.9 1.0

22 20.8 24.0 0.8 0.9

23 22.6 18.8 0.9 0.8

24 18.1 17.1 0.8 0.9

25 25.7 16.4 0.8 0.6

26 20.3 17.2 1.0 0.8

27 27.5 28.6 0.7 0.9

28 17.3 15.3 0.6 0.8

29 10.4 19.2 1.0 1.1

30 14.7 24.2 1.0 1.1

31 13.4 17.7 1.0 1.0

94

c. Kadar urea dan kreatinin perlakuan multivitamin mineral


Sebelum Sesudah Sebelum Sesudah

1 15.1 22.3 0.8 0.9

2 20.8 14.5 1.0 0.6

3 14.7 13.4 0.7 0.6

4 21.6 21.4 1.0 0.7

5 18.7 27.4 0.9 1.0

6 11.1 11.2 0.7 0.7

7 18.0 22.9 0.7 0.9

8 19.3 20.6 0.7 0.8

9 21.2 23.6 0.9 0.7

10 16.8 19.7 0.9 0.6

11 19.3 18.2 0.7 0.6

12 33.6 22.3 0.9 0.9

13 18.0 19.4 0.8 0.8

14 37.4 25.3 0.9 0.7

15 19.8 21.5 0.9 1.0

16 23.5 15.1 0.7 0.7

17 12.9 19.2 0.6 0.7

18 18.2 20.0 0.9 0.9

19 25.0 30.6 0.9 0.8

20 24.3 22.4 0.9 0.8

21 26.8 18.5 0.8 0.9

22 30.8 22.0 0.8 0.9

23 19.3 23.6 0.8 0.9

24 11.4 19.4 0.8 0.9

25 23.9 24.3 0.7 0.8

26 28.7 23.1 0.8 0.6

27 29.2 23.0 1.0 0.7

28 30.4 23.4 0.9 0.8

29 24.0 26.5 1.0 1.0

30 23.2 26.8 0.9 0.8

31 27.8 22.8 0.8 0.6

95

Lampiran 10 Frekuensi konsumsi wanita pekerja dari makanan sebelum dan setelah suplementasi

1a Frekuensi konsumsi makanan sumber karbohidrat sebelum suplementasi (%)

Frekuensi

Nasi Mie Roti Jagung Biskuit Ubijalar

Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM

2-3x/hari 100.0 96.8 96.8 3.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

1x/hari 0.0 3.2 3.2 3.2 9.7 6.5 6.5 6.5 9.7 3.2 0.0 0.0 0.0 12.9 0.0 0.0 3.2 0.0

3-5x/mg 0.0 0.0 0.0 19.4 38.7 35.5 29.0 22.6 25.8 3.2 6.5 6.5 9.7 12.9 32.3 0.0 9.7 3.2

1-2x/mg 0.0 0.0 0.0 61.3 29.0 48.4 41.9 54.8 48.4 51.6 25.8 19.4 35.5 25.8 32.3 25.8 25.8 29.0

2-3x/bln 0.0 0.0 0.0 6.5 9.7 0.0 12.9 9.7 6.5 6.5 12.9 19.4 16.1 6.5 9.7 19.4 16.1 0.0

1x/bln 0.0 0.0 0.0 3.2 12.9 9.7 3.2 3.2 3.2 16.1 32.3 22.6 9.7 22.6 12.9 29.0 25.8 29.0

Tidak pernah 0.0 0.0 0.0 3.2 0.0 0.0 3.2 3.2 6.5 19.4 22.6 32.3 29.0 19.4 12.9 25.8 19.4 38.7

1b Frekuensi konsumsi makanan sumber karbohidrat setelah suplementasi (%)

Frekuensi

Nasi Mie Roti Jagung Biskuit Ubijalar


2-3x/hari 100.0 100.0 100.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.2 0.0 0.0 0.0 0.0

1x/hari 0.0 0.0 0.0 0.0 0.0 6.5 9.7 6.5 12.9 3.2 0.0 3.2 0.0 6.5 16.1 0.0 0.0 0.0

3-5x/mg 0.0 0.0 0.0 29.0 45.2 35.5 25.8 19.4 19.4 3.2 16.1 3.2 9.7 6.5 6.5 0.0 3.2 0.0

1-2x/mg 0.0 0.0 0.0 54.8 41.9 48.4 48.4 54.8 58.1 58.1 32.3 45.2 51.6 35.5 35.5 19.4 25.8 16.1

2-3x/bln 0.0 0.0 0.0 9.7 9.7 0.0 3.2 3.2 3.2 12.9 12.9 6.5 6.5 9.7 9.7 19.4 3.2 9.7

1x/bln 0.0 0.0 0.0 3.2 0.0 6.5 6.5 9.7 6.5 12.9 29.0 29.0 19.4 12.9 22.6 32.3 29.0 25.8

Tidak pernah 0.0 0.0 0.0 3.2 0.0 3.2 6.5 6.5 0.0 9.7 9.7 12.9 9.7 25.8 9.7 29.0 38.7 48.4

96

2a Frekuensi konsumsi makanan sumber protein nabati sebelum suplementasi (%)

Frekuensi

Kc. Hijau Kc. Merah Melinjo Tempe Tahu Oncom


2-3x/hari 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 6.5 9.7 0.0 6.5 0.0 0.0 0.0 0.0

1x/hari 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 29.0 32.3 9.7 22.6 16.1 16.1 3.2 0.0 0.0

3-5x/mg 3.2 6.5 0.0 3.2 0.0 3.2 3.2 3.2 3.2 41.9 38.7 51.6 51.6 51.6 51.6 3.2 6.5 0.0

1-2x/mg 29.0 25.8 29.0 6.5 9.7 16.1 41.9 32.3 12.9 22.6 19.4 25.8 25.8 19.4 25.8 16.1 29.0 32.3

2-3x/bln 9.7 9.7 12.9 3.2 0.0 6.5 9.7 3.2 9.7 0.0 0.0 3.2 0.0 6.5 3.2 16.1 16.1 6.5

1x/bln 29.0 19.4 12.9 9.7 9.7 9.7 12.9 16.1 22.6 0.0 3.2 0.0 0.0 0.0 0.0 22.6 22.6 16.1

Tidak pernah 29.0 35.5 45.2 77.4 80.6 64.5 29.0 45.2 48.4 6.5 0.0 0.0 0.0 0.0 3.2 38.7 25.8 45.2

2b Frekuensi konsumsi makanan sumber protein nabati setelah suplementasi (%)

Frekuensi

Kc. Hijau Kc. Merah Melinjo Tempe Tahu Oncom


2-3x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0

1x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 12.9 29.0 16.1 6.5 19.4 0.0 0.0 0.0

3-5x/mg 3.2 3.2 0.0 3.2 0.0 0.0 3.2 3.2 3.2 45.2 51.6 35.5 54.8 51.6 35.5 3.2 0.0 6.5

1-2x/mg 41.9 29.0 19.4 16.1 9.7 9.7 48.4 45.2 22.6 22.6 32.3 22.6 29.0 38.7 38.7 22.6 35.5 16.1

2-3x/bln 6.5 0.0 12.9 0.0 0.0 6.5 19.4 6.5 9.7 6.5 3.2 0.0 0.0 0.0 0.0 3.2 3.2 9.7

1x/bln 25.8 29.0 29.0 9.7 12.9 12.9 3.2 19.4 12.9 0.0 0.0 3.2 0.0 0.0 3.2 41.9 29.0 25.8

Tidak pernah 22.6 38.7 38.7 71.0 77.4 71.0 25.8 25.8 51.6 3.2 0.0 3.2 0.0 3.2 3.2 29.0 32.3 41.9

97

3a Frekuensi konsumsi makanan sumber protein hewani sebelum suplementasi (%)

Frekuensi

Telur Ayam Daging sapi Hati sapi Hati ayam Ikan segar


2-3x/hari 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

1x/hari 25.8 19.4 19.4 0.0 0.0 3.2 0.0 0.0 0.0 3.2 0.0 0.0 3.2 0.0 0.0 3.2 0.0 0.0

3-5x/mg 45.2 48.4 48.4 16.1 9.7 16.1 6.5 0.0 0.0 0.0 0.0 0.0 12.9 9.7 3.2 12.9 9.7 3.2

1-2x/mg 25.8 29.0 19.4 45.2 67.7 71.0 9.7 6.5 3.2 3.2 0.0 3.2 25.8 32.3 25.8 25.8 32.3 25.8

2-3x/bln 0.0 0.0 3.2 25.8 19.4 6.5 12.9 6.5 6.5 3.2 6.5 3.2 16.1 12.9 19.4 16.1 12.9 19.4

1x/bln 0.0 0.0 3.2 9.7 3.2 3.2 6.5 32.3 29.0 3.2 19.4 6.5 22.6 25.8 19.4 22.6 25.8 19.4

Tidak pernah 3.2 3.2 0.0 3.2 0.0 0.0 64.5 54.8 61.3 87.1 74.2 87.1 19.4 19.4 32.3 19.4 19.4 32.3

3b Frekuensi konsumsi makanan sumber protein hewani setelah suplementasi (%)

Frekuensi

Telur Ayam Daging sapi Hati sapi Hati ayam Ikan segar


2-3x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

1x/hari 12.9 12.9 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.2

3-5x/mg 61.3 48.4 51.6 16.1 22.6 19.4 3.2 6.5 3.2 0.0 0.0 0.0 3.2 6.5 3.2 19.4 22.6 0.0

1-2x/mg 25.8 32.3 35.5 64.5 67.7 67.7 6.5 6.5 9.7 0.0 3.2 6.5 51.6 41.9 32.3 51.6 54.8 64.5

2-3x/bln 0.0 3.2 3.2 12.9 3.2 12.9 19.4 3.2 3.2 0.0 3.2 0.0 9.7 12.9 12.9 9.7 0.0 12.9

1x/bln 0.0 3.2 0.0 3.2 3.2 0.0 16.1 29.0 29.0 9.7 16.1 9.7 9.7 12.9 19.4 12.9 16.1 6.5

Tidak pernah 0.0 0.0 0.0 3.2 3.2 0.0 54.8 54.8 54.8 90.3 77.4 83.9 22.6 25.8 32.3 6.5 6.5 12.9

98

4a Frekuensi konsumsi sayur-sayuran sebelum suplementasi (%)

Frekuensi

Bayam Kangkung Daun singkong Kacang panjang Selada air Sawi Daun katuk

Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM

2-3x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0

1x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

3-5x/mg 25.8 29.0 19.4 19.4 25.8 12.9 29.0 12.9 6.5 32.3 9.7 3.2 3.2 0.0 0.0 32.3 19.4 19.4 3.2 0.0 0.0

1-2x/mg 48.4 38.7 45.2 51.6 41.9 48.4 32.3 38.7 51.6 41.9 67.7 64.5 6.5 9.7 6.5 41.9 64.5 45.2 19.4 6.5 3.2

2-3x/bln 0.0 9.7 9.7 0.0 9.7 6.5 6.5 16.1 12.9 3.2 6.5 12.9 3.2 0.0 6.5 9.7 0.0 6.5 0.0 0.0 3.2

1x/bln 3.2 9.7 9.7 6.5 19.4 16.1 12.9 22.6 9.7 12.9 12.9 3.2 3.2 6.5 9.7 3.2 6.5 12.9 3.2 9.7 9.7

Tidak pernah 22.6 12.9 16.1 22.6 3.2 16.1 19.4 6.5 19.4 9.7 3.2 16.1 83.9 83.9 77.4 12.9 9.7 12.9 74.2 83.9 83.9

4b Frekuensi konsumsi sayur-sayuran setelah suplementasi (%)

Frekuensi

Bayam Kangkung Daun singkong Kacang panjang Selada air Sawi Daun katuk

Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM Plasebo

Vit.

C MVM

2-3x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

1x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0

3-5x/mg 16.1 12.9 19.4 12.9 9.7 16.1 12.9 6.5 6.5 25.8 16.1 3.2 3.2 0.0 0.0 12.9 25.8 12.9 0.0 0.0 0.0

1-2x/mg 51.6 45.2 61.3 48.4 58.1 61.3 38.7 58.1 51.6 54.8 64.5 61.3 12.9 3.2 3.2 64.5 45.2 64.5 12.9 6.5 0.0

2-3x/bln 12.9 16.1 0.0 6.5 6.5 0.0 12.9 9.7 9.7 6.5 0.0 12.9 3.2 0.0 3.2 3.2 3.2 6.5 0.0 0.0 6.5

1x/bln 6.5 12.9 3.2 12.9 16.1 0.0 12.9 9.7 6.5 3.2 9.7 9.7 12.9 9.7 6.5 12.9 6.5 3.2 9.7 9.7 16.1

Tidak pernah 12.9 12.9 16.1 19.4 9.7 22.6 22.6 16.1 25.8 9.7 9.7 12.9 67.7 87.1 87.1 6.5 19.4 9.7 77.4 83.9 77.4

99

5a Frekuensi konsumsi buah-buahan sebelum suplementasi (%)

Frekuensi

Jambu biji Pepaya Jeruk Salak

Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM

2-3x/hari 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 3.2 0.0 0.0 0.0

1x/hari 3.2 3.2 0.0 3.2 0.0 0.0 9.7 3.2 3.2 3.2 0.0 0.0

3-5x/mg 19.4 19.4 16.1 9.7 12.9 12.9 35.5 35.5 48.4 22.6 22.6 3.2

1-2x/mg 45.2 41.9 45.2 45.2 29.0 35.5 35.5 58.1 35.5 22.6 25.8 41.9

2-3x/bln 3.2 3.2 6.5 3.2 9.7 12.9 9.7 3.2 6.5 3.2 3.2 12.9

1x/bln 3.2 9.7 6.5 6.5 19.4 9.7 3.2 0.0 0.0 16.1 16.1 12.9

Tidak pernah 25.8 22.6 25.8 32.3 29.0 29.0 3.2 0.0 3.2 32.3 32.3 29.0

5b Frekuensi konsumsi buah-buahan setelah suplementasi (%)

Frekuensi

Jambu biji Pepaya Jeruk Salak

Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM Plasebo Vit. C MVM

2-3x/hari 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

1x/hari 0.0 9.7 0.0 0.0 0.0 0.0 6.5 9.7 12.9 3.2 0.0 0.0

3-5x/mg 16.1 12.9 22.6 12.9 12.9 3.2 45.2 32.3 58.1 0.0 0.0 9.7

1-2x/mg 38.7 25.8 38.7 48.4 45.2 54.8 41.9 54.8 29.0 35.5 38.7 29.0

2-3x/bln 6.5 6.5 3.2 6.5 3.2 6.5 6.5 3.2 0.0 12.9 3.2 9.7

1x/bln 9.7 19.4 9.7 9.7 12.9 12.9 0.0 0.0 0.0 16.1 19.4 6.5

Tidak pernah 29.0 25.8 25.8 22.6 25.8 22.6 0.0 0.0 0.0 32.3 38.7 45.2

100

6 Frekuensi konsumsi susu bubuk sebelum dan setelah suplementasi (%)

Frekuensi

Sebelum Setelah

Plasebo Vit. C MVM Plasebo Vit. C MVM

2-3x/hari 0.0 0.0 0.0 0.0 0.0 0.0

1x/hari 6.5 6.5 3.2 3.2 0.0 3.2

3-5x/mg 0.0 9.7 9.7 0.0 3.2 6.5

1-2x/mg 3.2 6.5 9.7 6.5 12.9 3.2

2-3x/bln 0.0 3.2 0.0 0.0 0.0 0.0

1x/bln 0.0 3.2 3.2 0.0 6.5 0.0

Tidak pernah 90.3 71.0 74.2 90.3 77.4 87.1

101

Lampiran 11 Konsumsi zat gizi wanita pekerja dari makanan sebelum dan setelah

suplementasi

a. Konsumsi zat gizi pada perlakuan plasebo (%)

Wanita pekerja

Sebelum Setelah

Energi

(kkal)

Protein

(g)

Vit. C

(mg)

Besi

(mg)

Energi

(kkal)

Protein

(g)

Vit. C

(mg)

Besi

(mg)

1 1665.5 51.9 21.5 11.8 1283.0 37.0 156.5 6.7

2 1010.0 40.0 42.5 5.8 1340.5 55.9 8.5 6.0

3 910.5 40.5 38.0 7.4 1060.0 28.7 10.0 12.5

4 954.5 29.0 42.0 3.1 1377.0 45.4 140.0 11.4

5 1432.0 44.1 12.0 10.2 1034.5 30.2 27.0 3.8

6 1375.0 48.8 12.0 6.3 1059.5 22.0 12.5 6.8

7 1165.0 46.9 20.0 5.2 811.0 33.5 40.5 4.9

8 954.0 41.9 10.0 3.2 1053.5 35.2 253.0 4.5

9 1619.0 32.0 16.0 3.9 1201.0 45.9 58.5 8.0

10 2244.0 52.0 27.0 13.4 546.5 16.1 10.0 3.8

11 1210.0 59.4 2.0 5.9 1019.5 49.7 94.0 39.4

12 641.0 28.3 9.0 5.3 933.5 31.1 12.5 4.5

13 2589.0 79.1 65.0 10.0 1109.0 30.3 44.0 5.3

14 1388.5 45.4 20.0 4.9 1052.5 29.2 11.0 3.8

15 1045.0 34.5 36.0 6.4 1237.5 36.3 26.5 8.2

16 1451.5 49.0 124.5 5.6 1676.5 62.5 17.5 10.4

17 621.0 23.6 9.0 3.1 1885.0 65.3 62.5 10.0

18 938.5 30.2 11.5 3.1 1211.0 31.7 28.5 6.4

19 1397.5 63.1 30.5 7.6 1312.5 45.6 43.5 6.6

20 1308.0 36.3 19.5 3.8 1354.0 44.4 96.5 6.2

21 1141.0 43.5 45.5 6.2 1402.0 35.1 24.5 8.9

22 1190.5 33.8 26.0 5.3 1567.5 44.5 127.5 10.2

23 1030.0 41.7 11.5 4.1 1791.5 54.0 33.5 14.1

24 1061.0 33.5 23.5 5.2 1390.0 55.2 59.5 8.1

25 1635.0 69.3 33.0 7.6 955.5 27.7 35.0 4.2

26 952.5 33.7 14.0 7.7 1646.5 64.5 113.5 9.5

27 1163.0 53.7 198.0 5.3 957.5 35.1 28.5 8.0

28 1180.5 36.3 112.0 8.3 1315.5 31.5 42.5 6.1

29 1209.5 39.4 121.5 4.2 1220.0 44.2 25.0 5.1

30 1239.0 33.7 210.0 6.6 1404.5 51.1 116.5 7.8

31 1127.5 31.1 23.0 3.4 1602.5 37.1 15.0 5.9

102

b. Konsumsi zat gizi pada perlakuan vitamin C (%)

Wanita

pekerja

Sebelum Setelah

Energi

(kkal)

Protein

(g)

Vit. C

(mg)

Besi

(mg)

Energi

(kkal)

Protein

(g)

Vit. C

(mg)

Besi

(mg)

1 1202.5 39.1 130.5 5.0 1334.0 45.2 40.0 7.3

2 743.0 30.5 39.5 25.4 985.5 33.4 111.5 4.2

3 842.5 29.0 29.5 6.3 1822.0 59.9 34.5 9.3

4 1118.5 41.9 46.5 4.2 831.0 23.5 21.5 4.1

5 1105.5 39.0 243.5 4.6 1474.5 43.0 11.0 7.1

6 1403.5 57.2 21.5 9.0 1235.0 47.2 13.5 10.1

7 1114.5 30.8 23.5 4.3 801.5 30.3 30.5 4.2

8 1149.0 38.5 28.5 7.7 724.5 25.2 3.5 4.1

9 556.0 20.2 43.0 6.8 831.0 26.8 21.5 3.4

10 1205.5 42.6 29.5 5.3 1149.5 38.1 42.5 4.8

11 1191.0 28.1 38.5 10.1 1114.0 47.0 6.5 5.5

12 1402.0 53.1 14.0 5.1 863.0 20.9 13.0 2.5

13 2519.0 75.2 142.5 12.7 1637.0 59.1 7.5 14.7

14 884.0 34.1 21.5 4.8 1433.0 49.1 43.5 8.2

15 1187.0 47.0 42.5 8.2 975.0 47.7 0.0 3.8

16 979.0 35.9 63.0 19.9 1144.5 39.5 27.5 6.6

17 1354.5 46.1 95.0 6.5 1435.5 41.4 10.0 6.0

18 1301.0 52.0 42.0 8.1 1071.5 38.4 30.5 4.6

19 1671.5 58.7 41.0 8.3 1074.5 39.0 18.0 5.4

20 1700.5 43.4 17.0 6.6 1074.0 40.9 15.5 5.5

21 1551.5 47.9 117.5 5.9 1274.0 38.9 3.0 3.7

22 1323.5 56.1 39.5 5.6 1387.5 44.3 23.5 6.7

23 1042.5 40.4 18.0 6.1 1148.5 38.0 4.5 3.2

24 1002.5 46.4 16.5 5.8 770.0 23.0 29.5 6.7

25 1503.5 48.7 22.0 7.8 1230.5 36.7 13.5 4.5

26 1187.0 30.2 50.5 5.1 805.5 28.6 32.5 5.2

27 293.0 7.0 8.0 3.8 1053.0 46.9 10.0 7.2

28 1308.0 47.2 115.0 7.9 918.5 36.2 221.0 6.2

29 885.0 24.7 35.0 3.4 1407.5 50.4 10.5 5.8

30 1099.0 28.9 45.5 3.6 862.0 27.8 5.0 2.3

31 1345.0 34.5 25.0 7.4 1178.0 36.9 192.5 8.6

103

c. Konsumsi zat gizi pada perlakuan multivitamin mineral

Wanita

pekerja

Sebelum Setelah

Energi

(kkal)

Protein

(g)

Vit. C

(mg)

Besi

(mg)

Energi

(kkal)

Protein

(g)

Vit. C

(mg)

Besi

(mg)

1 1008.5 47.1 24.0 4.8 1183.5 38.2 49.5 7.1

2 1212.0 39.2 9.5 4.2 1072.0 35.9 7.0 7.0

3 811.0 25.8 14.0 4.8 1701.5 61.9 43.5 9.1

4 1162.5 38.7 192.5 3.5 1149.5 39.0 15.5 5.7

5 1625.0 62.0 10.0 6.2 1318.5 56.4 50.0 8.6

6 1225.0 47.9 77.0 4.0 2088.0 74.3 76.5 8.4

7 554.0 28.8 3.5 2.1 1288.5 59.0 21.5 7.1

8 1156.0 35.9 21.0 4.2 1023.0 23.5 30.0 5.6

9 1401.0 56.5 204.0 7.5 802.0 32.2 46.5 5.1

10 981.0 42.4 24.5 7.2 1247.5 35.3 26.0 4.4

11 1347.0 54.5 25.5 5.0 1198.5 49.9 60.0 5.1

12 934.0 39.9 26.5 4.2 1186.0 33.9 16.0 9.1

13 1115.5 38.6 24.5 4.9 1075.5 41.8 44.0 8.6

14 1560.5 51.0 5.0 7.1 1388.0 41.4 130.0 9.4

15 1464.5 51.4 3.5 6.7 1186.0 45.1 51.5 5.7

16 1279.5 43.7 12.5 6.8 1280.5 43.0 40.0 5.4

17 1266.0 45.6 7.0 6.4 1608.5 35.6 54.5 9.1

18 631.0 21.2 0.0 2.0 1271.0 34.5 33.0 5.1

19 1220.5 46.0 16.0 3.7 1135.0 35.0 24.0 4.9

20 422.0 12.8 6.0 1.6 2295.0 70.4 33.5 7.6

21 1036.5 42.7 19.0 3.7 1168.5 42.6 47.5 4.7

22 958.0 27.8 100.5 5.6 1141.5 35.8 39.5 6.1

23 571.0 24.2 14.0 3.4 1432.5 39.7 22.5 7.2

24 623.5 19.1 3.5 1.9 1581.5 38.5 257.5 5.9

25 962.0 30.2 16.0 3.8 2499.0 75.9 36.5 13.6

26 1054.5 28.1 21.5 5.9 958.0 23.2 35.0 3.3

27 778.0 15.3 26.5 3.9 1435.5 51.1 34.5 8.7

28 619.0 24.3 2.0 4.1 1416.0 42.9 80.5 8.0

29 701.0 25.8 21.5 4.5 1461.5 34.5 22.5 4.9

30 841.5 25.9 29.5 3.7 1531.0 54.3 41.0 9.0

31 1062.5 39.6 11.5 4.7 1431.0 66.2 405.0 19.2

104

Lampiran 12 Tingkat konsumsi zat gizi wanita pekerja dari makanan sebelum

dan setelah suplementasi

a. Tingkat konsumsi zat gizi pada perlakuan plasebo (%)

Wanita

pekerja

Sebelum Setelah

Energi Protein Vit. C Besi Energi Protein Vit. C Besi

1 115.4 136.6 28.7 45.4 86.7 95.0 208.7 25.6

2 46.6 66.4 56.7 22.4 62.4 93.7 11.3 23.0

3 40.7 65.2 50.7 28.5 47.6 46.4 13.3 48.0

4 54.0 62.3 56.0 11.7 78.5 98.4 186.7 43.9

5 59.2 69.2 16.0 39.4 42.1 46.8 36.0 14.6

6 72.7 92.9 16.0 24.1 54.0 40.2 16.7 26.2

7 62.6 95.9 26.7 20.1 44.1 69.3 54.0 18.9

8 60.4 100.9 13.3 12.5 66.1 83.9 337.3 17.3

9 94.4 67.1 21.3 15.1 72.7 99.9 78.0 30.9

10 119.0 99.4 36.0 51.4 28.9 30.7 13.3 14.6

11 75.5 133.3 2.7 22.7 61.3 107.5 125.3 151.6

12 35.2 58.9 12.0 20.4 50.7 64.1 16.7 17.2

13 165.6 192.3 86.7 38.4 69.8 72.5 58.7 20.5

14 97.3 114.5 26.7 18.9 73.4 73.4 14.7 14.6

15 72.4 86.0 48.0 24.6 86.9 91.9 35.3 31.4

16 96.2 117.0 166.0 21.5 113.3 152.1 23.3 40.0

17 27.9 38.2 12.0 11.9 86.4 107.7 83.3 38.4

18 50.5 61.6 15.3 12.0 64.7 64.4 38.0 24.7

19 81.4 139.7 40.7 29.4 76.1 100.5 58.0 25.5

20 67.5 67.4 26.0 14.6 69.0 81.4 128.7 23.7

21 55.7 80.6 60.7 23.9 71.1 67.7 32.7 34.1

22 77.0 83.2 34.7 20.5 99.5 107.4 170.0 39.2

23 74.6 108.6 15.3 15.6 132.5 143.8 44.7 54.4

24 45.1 54.1 31.3 19.9 58.1 87.7 79.3 31.0

25 77.2 117.9 44.0 29.3 45.6 47.5 46.7 16.1

26 40.7 54.7 18.7 29.5 70.1 104.2 151.3 36.7

27 56.9 99.9 264.0 20.3 47.8 66.5 38.0 30.6

28 55.4 61.4 149.3 32.0 61.2 52.8 56.7 23.5

29 66.2 77.6 162.0 16.2 69.2 90.3 33.3 19.4

30 50.4 49.4 280.0 25.3 57.0 74.6 155.3 30.0

31 63.9 63.4 30.7 13.2 89.8 74.8 20.0 22.7

105

b. Tingkat konsumsi zat gizi pada perlakuan vitamin C (%)

Wanita

pekerja

Sebelum Setelah


1 71.6 83.9 174.0 19.2 78.7 96.0 53.3 28.1

2 51.4 80.1 52.7 97.7 68.8 88.7 148.7 16.3

3 58.7 76.7 39.3 24.1 125.9 157.4 46.0 35.8

4 63.6 85.9 62.0 16.3 48.5 49.4 28.7 15.6

5 69.9 88.9 324.7 17.6 89.9 94.3 14.7 27.3

6 67.8 99.5 28.7 34.5 60.9 83.8 18.0 38.9

7 86.9 91.4 31.3 16.4 63.4 91.1 40.7 16.2

8 79.6 96.1 38.0 29.5 50.0 62.5 4.7 15.6

9 28.2 38.9 57.3 26.1 42.4 51.8 28.7 13.2

10 69.4 88.3 39.3 20.5 68.3 81.6 56.7 18.5

11 54.8 46.5 51.3 38.7 51.1 77.6 8.7 21.3

12 83.6 120.2 18.7 19.6 51.6 47.5 17.3 9.8

13 145.8 156.8 190.0 49.0 96.4 125.3 10.0 56.5

14 39.6 58.1 28.7 18.4 64.8 84.4 58.0 31.5

15 64.8 97.5 56.7 31.6 54.6 101.3 0.0 14.6

16 60.2 83.9 84.0 76.6 70.1 92.0 36.7 25.2

17 91.8 112.4 126.7 25.0 92.2 95.8 13.3 23.1

18 84.2 121.1 56.0 31.3 70.0 90.3 40.7 17.8

19 112.3 141.8 54.7 31.9 74.5 97.4 24.0 20.7

20 104.8 96.2 22.7 25.3 65.8 90.2 20.7 21.2

21 72.7 80.8 156.7 22.6 72.1 79.3 4.0 14.0

22 61.7 99.4 52.7 21.6 63.9 77.6 31.3 25.7

23 70.0 97.7 24.0 23.6 76.6 91.4 6.0 12.2

24 42.3 74.3 22.0 22.4 32.7 37.1 39.3 25.6

25 80.6 94.0 29.3 29.9 65.1 69.9 18.0 17.1

26 65.2 59.7 67.3 19.5 44.0 56.3 43.3 19.9

27 15.0 12.8 10.7 14.8 52.9 84.8 13.3 27.6

28 81.2 111.4 153.3 30.6 58.9 88.1 294.7 24.0

29 60.4 60.7 46.7 13.0 96.4 124.2 14.0 22.3

30 53.1 53.1 60.7 13.7 42.6 52.2 6.7 8.9

31 96.9 89.5 33.3 28.5 85.5 96.5 256.7 33.1

106

c. Tingkat konsumsi zat gizi pada perlakuan multivitamin mineral (%)

Wanita

pekerja

Sebelum Setelah


1 50.5 89.5 32.0 18.5 60.0 73.5 66.0 27.3

2 72.9 84.9 12.7 16.2 67.5 81.3 9.3 26.8

3 50.2 60.7 18.7 18.4 103.7 143.4 58.0 35.0

4 84.6 101.4 256.7 13.4 83.2 101.6 20.7 21.9

5 103.4 142.0 13.3 23.7 83.4 128.3 66.7 33.0

6 77.1 114.5 102.7 15.5 132.6 179.3 102.0 32.2

7 28.9 54.1 4.7 8.1 66.8 110.2 28.7 27.4

8 76.4 90.2 28.0 16.3 66.0 57.6 40.0 21.7

9 81.1 117.7 272.0 28.9 46.2 66.8 62.0 19.4

10 50.9 79.2 32.7 27.7 64.6 65.8 34.7 16.9

11 62.2 90.6 34.0 19.2 57.0 85.4 80.0 19.8

12 59.5 91.5 35.3 16.3 74.9 77.1 21.3 35.0

13 55.7 73.3 32.7 18.9 54.1 79.9 58.7 33.1

14 86.1 101.2 6.7 27.3 76.3 81.8 173.3 36.0

15 82.3 109.8 4.7 25.8 65.3 94.3 68.7 21.9

16 66.6 81.8 16.7 26.2 67.9 82.1 53.3 20.8

17 81.1 105.2 9.3 24.5 106.2 84.5 72.7 35.1

18 42.0 50.9 0.0 7.8 86.5 84.4 44.0 19.7

19 68.4 92.9 21.3 14.2 65.8 73.1 32.0 18.7

20 22.1 24.1 8.0 6.3 117.1 129.3 44.7 29.3

21 57.4 85.1 25.3 14.1 66.2 86.9 63.3 18.1

22 71.1 78.2 134.0 21.5 84.4 100.7 52.7 23.3

23 32.7 52.6 18.7 13.1 83.2 87.7 30.0 27.7

24 27.2 31.8 4.7 7.2 69.1 64.0 343.3 22.6

25 52.2 59.0 21.3 14.5 134.9 147.5 48.7 52.2

26 62.3 59.8 28.7 22.6 55.6 48.4 46.7 12.9

27 45.3 32.0 35.3 15.0 84.2 107.9 46.0 33.5

28 33.9 50.5 2.7 15.9 79.6 91.5 107.3 30.7

29 39.0 51.8 28.7 17.3 83.5 70.8 30.0 18.8

30 40.4 47.3 39.3 14.4 74.2 99.9 54.7 34.7

31 50.9 68.2 15.3 18.3 69.6 116.0 540.0 73.7

107

Lampiran 13 Uji Anova konsumsi wanita pekerja sebelum dan setelah

suplementasi

ANOVA

Variabel Jumlah kuadrat db Kuadrat tengah F Sig.

Sebelum

Energi Antar perlakuan 933403.973 2 466701.987 3.424 0.037

Dalam perlakuan 12268841.710 90 136320.463

Total 13202245.683 92

Protein Antar perlakuan 618.743 2 309.371 1.873 0.160

Dalam perlakuan 14863.184 90 165.146

Total 15481.927 92

Vitamin C Antar perlakuan 7434.473 2 3717.237 1.444 0.241

Dalam perlakuan 231710.355 90 2574.559

Total 239144.828 92

Besi Antar perlakuan 128.200 2 64.100 6.367 0.003

Dalam perlakuan 906.106 90 10.068

Total 1034.306 92

Setelah

Energi Antar perlakuan 909318.167 2 454659.083 4.611 0.012

Dalam perlakuan 8875111.065 90 98612.345

Total 9784429.231 92

Protein Antar perlakuan 602.524 2 301.262 2.032 0.137

Dalam perlakuan 13343.725 90 148.264

Total 13946.249 92

Vitamin C Antar perlakuan 13137.973 2 6568.987 1.669 0.194

Dalam perlakuan 354195.774 90 3935.509

Total 367333.747 92

Besi Antar perlakuan 94.043 2 47.021 2.519 0.086


Total 1774.075 92

*Perbedaan rata-rata bermakna pada taraf 0,05

108

Uji Post Hoc

Perbandingan Ganda

Bonferroni

Variabel

tergantung

Perlakuan

(I)

Perlakuan

(J)

Beda

rata-rata

Std.

Error Sig.

Selang kepercayaan

95%

(I-J)

Batas

bawah

Batas

atas

Energi Plasebo Vit. C 54.145 93.781 1.000 -174.638 282.928

(sebelum MVM 234.355* 93.781 0.043 5.572 463.138

supl.) Vit. C Plasebo -54.145 93.781 1.000 -282.928 174.638

MVM 180.210 93.781 0.173 -48.574 408.993

MVM Plasebo -234.355* 93.781 0.043 -463.138 -5.572

Vit. C -180.210 93.781 0.173 -408.993 48.574

Besi Plasebo Vit. C -1.333 0.806 0.305 -3.299 0.633

(sebelum MVM 1.541 0.806 0.177 -0.425 3.507

supl.) Vit. C Plasebo 1.333 0.806 0.305 -0.633 3.299

MVM 2.873* 0.806 0.002 0.907 4.840

MVM Plasebo -1.541 0.806 0.177 -3.507 0.425

Vit. C -2.873* 0.806 0.002 -4.840 -0.907

Energi Plasebo Vit. C 121.452 79.763 0.394 -73.133 316.037

(setelah MVM -120.758 79.763 0.401 -315.343 73.827

supl.) Vit. C Plasebo -121.452 79.763 0.394 -316.037 73.133

MVM -242.210* 79.763 0.009 -436.795 -47.625

MVM Plasebo 120.758 79.763 0.401 -73.827 315.343

Vit. C 242.210* 79.763 0.009 47.625 436.795


109

Lampiran 14 Uji Anova tingkat konsumsi wanita pekerja sebelum dan setelah

suplementasi

ANOVA

Variabel

Jumlah

kuadrat db

Kuadrat

tengah F Sig.

Sebelum

Tkt. kons. energi Antar perlakuan 2778.212 2 1389.106 2.288 0.107

Dalam perlakuan 54645.150 90 607.168

Total 57423.362 92

Tkt. kons. protein Antar perlakuan 2413.967 2 1206.984 1.321 0.272

Dalam perlakuan 82204.118 90 913.379

Total 84618.085 92

Tkt. kons. vit. C Antar perlakuan 13216.841 2 6608.421 1.444 0.241

Dalam perlakuan 411929.520 90 4576.995

Total 425146.361 92

Tkt. kons. besi Antar perlakuan 1896.451 2 948.225 6.367 0.003

Dalam perlakuan 13403.938 90 148.933

Total 15300.388 92

Setelah

Tkt. kons. energi Antar perlakuan 2288.487 2 1144.244 2.636 0.077

Dalam perlakuan 39061.942 90 434.022

Total 41350.429 92

Tkt. kons. protein Antar perlakuan 2368.936 2 1184.468 1.615 0.205

Dalam perlakuan 65998.833 90 733.320

Total 68367.768 92

Tkt. kons. vit. C Antar perlakuan 23356.397 2 11678.198 1.669 0.194

Dalam perlakuan 629681.376 90 6996.460

Total 653037.773 92

Tkt. kons. besi Antar perlakuan 1391.161 2 695.581 2.519 0.086

Dalam perlakuan 24852.559 90 276.140

Total 26243.720 92


110

Uji Post Hoc

Perbandingan Ganda

Bonferroni

Variabel

tergantung

Perlakuan

(I)

Perlakuan

(J)

Beda

rata-rata

Std.

Error Sig.

Selang kepercayaan

95%

(I-J)

Batas

bawah

Batas

atas

Tkt. kons. besi Plasebo Vit. C -5.126 3.100 0.305 -12.688 2.436

(sebelum supl.) MVM 5.926 3.100 0.177 -1.636 13.488

Vit. C Plasebo 5.126 3.100 0.305 -2.436 12.688

MVM 11.052* 3.100 0.002 3.490 18.614

MVM Plasebo -5.926 3.100 0.177 -13.488 1.636

Vit. C -11.052* 3.100 0.002 -18.614 -3.490


111

Lampiran 15 Uji Anova antropometri, tekanan darah, urea, dan kreatinin wanita

pekerja

Variabel

Jumlah

kuadrat db

Kuadrat

tengah F Sig.

Berat badan Antar perlakuan 186.971 2 93.485 1.344 0.266

sebelum Dalam perlakuan 6261.892 90 69.577

Total 6448.863 92

Berat badan Antar perlakuan 245.107 2 122.554 1.840 0.165

setelah Dalam perlakuan 5994.986 90 66.611

Total 6240.093 92

IMT sebelum Antar perlakuan 21.988 2 10.994 1.091 0.340


Total 929.116 92

Tek. darah Antar perlakuan 36.022 2 18.011 0.124 0.884

sistolik sebelum Dalam perlakuan 13091.935 90 145.466

Total 13127.957 92

Tek. darah Antar perlakuan 8.602 2 4.301 0.083 0.920

diastolik sebelum Dalam perlakuan 4638.710 90 51.541

Total 4647.312 92

Urea sebelum Antar perlakuan 159.758 2 79.879 2.677 0.074


Total 2845.452 92

Kreatinin sebelum Antar perlakuan 0.006 2 0.003 0.229 0.796


Total 1.190 92

112

Lampiran 16 Uji Ancova IMT wanita pekerja setelah suplementasi

Uji Efek Antar Subjek

Variabel dependen: IMT

Sumber Jumlah Kuadrat Tipe III db Kuadrat Tengah F Sig.

Model terkoreksi 112.684 4 28.171 2.968 0.024

Intercept 380.975 1 380.975 40.142 0.000

Perlakuan 33.391 2 16.695 1.759 0.178

Usia 81.587 1 81.587 8.597 0.004

Konsumsi energi 1.935 1 1.935 0.204 0.653

Galat 835.182 88 9.491

Total 50642.920 93

Total terkoreksi 947.866 92

a R Squared = .119 (Adjusted R Squared = .079)

Estimasi

Variabel dependen: IMT

Perlakuan Rata-rata Std. Error Selang Kepercayaan 95%

Batas bawah Batas atas

Plasebo 23.877a 0.555 22.775 24.981

Vit. C 22.390a 0.568 21.262 23.519

MVM 23.080a 0.568 21.952 24.208

a Covariates appearing in the model are evaluated at the following values: Usia = 31.75,

konsumsi energi = 1251.7204

113

Lampiran 17 Uji Ancova lama sakit wanita pekerja selama suplementasi


Variabel dependen: lama sakit


Model terkoreksi 214.299 10 21.430 1.448 0.174

Intercept 0.865 1 0.865 0.058 0.810

Perlakuan 77.477 2 38.738 2.618 0.079

Usia 9.978 1 9.978 0.674 0.414

IMT 9.878 1 9.878 0.668 0.416

Tek. darah sistolik 4.356 1 4.356 0.294 0.589

Tek. darah diastolik 20.209 1 20.209 1.366 0.246

Konsumsi energi 1.474 1 1.474 0.100 0.753

Konsumsi protein 1.537 1 1.537 0.104 0.748

Konsumsi vit. C 22.273 1 22.273 1.505 0.223

Konsumsi besi 21.923 1 21.923 1.482 0.227

Galat 1213.314 82 14.797

Total 2229.000 93



Estimasi

Variabel dependen: lama sakit Perlakuan Rata-rata Std. Error Selang Kepercayaan 95%


Plasebo 4.329 0.732 2.873 5.785

Vit. C 2.008 0.744 0.527 3.488

MVM 2.470 0.714 1.049 3.890


IMT = 23.116, sistolik = 97.42, diastolik = 65.27, konsumsi energi = 1251.7204, konsumsi

protein = 41.3968, konsumsi vit. C = 50.4946, konsumsi besi = 7.1695.

114

Lampiran 18 Uji Ancova tekanan darah sistolik wanita pekerja setelah

suplementasi


Variabel dependen: tekanan darah sistolik


Model terkoreksi 1485.405a 5 297.081 2.781 0.022

Intercept 11310.049 1 11310.049 105.858 0.000

Perlakuan 515.542 2 257.771 2.413 0.096

Usia 1025.084 1 1025.084 9.594 0.003

Berat badan 621.693 1 621.693 5.819 0.018

Konsumsi natrium 0.250 1 0.250 0.002 0.962

Galat 9295.240 87 106.842

Total 893400.000 93



Estimasi

Variabel dependen: tekanan darah sistolik Perlakuan Rata-rata Std. Error Selang Kepercayaan 95%


Plasebo 100.593a 1.897 96.822 104.364

Vit. C 94.653a 1.895 90.886 98.420

MVM 97.012a 1.876 93.283 100.741


berat badan = 52.375, konsumsi natrium = 283.8333.

115

Lampiran 19 Uji Ancova tekanan darah diastolik wanita pekerja setelah

suplementasi


Variabel dependen: tekanan darah diastolik



Intercept 4713.614 1 4713.614 109.843 0.000

Perlakuan 144.866 2 72.433 1.688 0.191

Usia 627.332 1 627.332 14.619 0.000

Berat badan 325.277 1 325.277 7.580 0.007

Konsumsi natrium 15.634 1 15.634 0.364 0.548

Galat 3733.353 87 42.912

Total 400700.000 93



Estimasi

Variabel dependen: tekanan darah diastolik



Plasebo 67.043a 1.202 64.653 69.432

Vit. C 63.996a 1.201 61.609 66.384

MVM 64.768a 1.189 62.405 67.131


berat badan = 52.375, konsumsi natrium = 283.8333.

116

Lampiran 20 Uji Ancova urea wanita pekerja setelah suplementasi


Variabel dependen: urea



Intercept 656.483 1 656.483 30.130 0.000

Perlakuan 4.119 2 2.059 0.095 0.910

Usia 0.744 1 0.744 0.034 0.854

Konsumsi protein 1.462 1 1.462 0.067 0.796

Galat 1917.351 88 21.788

Total 43498.550 93


a R Squared = .004 (Adjusted R Squared = -.041)

Estimasi

Variabel dependen: urea



Plasebo 21.174a 0.842 19.501 22.846

Vit. C 20.866a 0.846 19.185 22.547

MVM 21.389a 0.850 19.699 23.079

a Covariates appearing in the model are evaluated at the following values: Usia = 31.75, konsumsi protein_2 = 41.3968.

117

Lampiran 21 Uji Ancova kreatinin wanita pekerja setelah suplementasi


Variabel dependen: kreatinin



Intercept 1.908 1 1.908 113.515 0.000

Perlakuan 0.135 2 0.068 4.017 0.021

Usia 0.060 1 0.060 3.552 0.063

Galat 1.496 89 0.017

Total 64.120 93



Estimasi




Plasebo 0.800a 0.023 0.753 0.846

Vit. C 0.873a 0.023 0.826 0.919

MVM 0.786a 0.023 0.739 0.832

a Covariates appearing in the model are evaluated at the following values: Usia = 31.75.

Uji Post Hoc


Bonferroni

Perlakuan Perlakuan Beda rata-rata Std. Error Sig. 95% Confidence Interval

(I) (J) (I-J) Batas bawah Batas atas

Plasebo Vit. C -0.073 0.033 0.089 -0.154 0.008

MVM 0.014 0.033 1.000 -0.067 0.095

Vit. C Plasebo 0.073 0.033 0.089 -0.008 0.154

MVM 0.087* 0.033 0.029 0.007 0.167

MVM Plasebo -0.014 0.033 1.000 -0.095 0.067

Vit. C -0.087* 0.033 0.029 -0.167 -0.007


118

Lampiran 22 Dokumentasi penelitian

Lokasi penelitian

Karyawati pabrik yang menjadi unit percobaan dalam penelitian

119

Pengukuran antropometri

Pengukuran tekanan darah

120

Pengambilan darah

Wawancara data frekuensi dan konsumsi pangan

Documents

Pengaruh Suplementasi Vitamin C dan Multivitamin Mineral ... · 2004. Minerals. Di dalam: Mahan LK, Escott-Stump S, editor. Krause’s Food ... Peranan gizi pada pencegahan dan penanggulangan